-+ 0.00%
-+ 0.00%
-+ 0.00%

Wells Fargo Maintains Overweight on Agilon Health, Lowers Price Target to $5

Benzinga·05/13/2025 18:10:33
Listen to the news
Wells Fargo analyst Stephen Baxter maintains Agilon Health (NYSE:AGL) with a Overweight and lowers the price target from $6 to $5.